Artiva Biotherapeutics, Inc. (ARTV) has 27 open-market insider trades by 11 insiders since 2024. Over the last six months insiders net bought $107.2M. The most active filer is RA Capital Management, L.P., Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Kolchinsky | Dir10% Owner | — | 1 | $100.0M | 2024-07-22 |
| RA Capital Management, L.P. | Dir10% Owner | — | 10 | $92.7M | 2026-07-31 |
| Yong-Jun Huh | Dir | — | 1 | $25.0M | 2024-07-22 |
| GC Corp. | 10% Owner | — | 1 | $16.5M | 2026-05-11 |
| 5AM Partners VI, LLC | 10% Owner | — | 1 | $10.0M | 2024-07-22 |
| Fred Aslan | CEO | — | 3 | $1.4M | 2026-10-06 |
| Christopher Horan | — | — | 2 | $179K | 2026-09-09 |
| Jennifer Bush | COOCLO | — | 2 | $173K | 2026-09-09 |
| Christopher Horan | — | — | 2 | $128K | 2026-10-05 |
| Subhashis Banerjee | — | — | 3 | $83K | 2026-10-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Fred Aslan | CEO | Sell | $169K | 2026-10-06 |
| Fred Aslan | CEO | Sell | $422K | 2026-10-05 |
| Christopher Horan | — | Sell | $71K | 2026-10-05 |
| Christopher Horan | COO & CLO | Sell | $57K | 2026-10-05 |
| Subhashis Banerjee | — | Sell | $8K | 2026-10-05 |
| Fred Aslan | CEO | Sell | $256K | 2026-09-08 |
Companies that share insiders with ARTV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jennifer Bush | COO & CLO | Sell | $94K | 2026-09-03 |
| Subhashis Banerjee | — | Sell | $12K | 2026-09-03 |
| Fred Aslan | CEO | Sell | $690K | 2026-09-03 |
| Christopher Horan | — | Sell | $116K | 2026-09-03 |
| Subhashis Banerjee | — | Sell | $99K | 2026-08-27 |
| Subhashis Banerjee | — | Sell | $5K | 2026-08-18 |
| RA Capital Management, L.P. | Director & 10% Owner | Buy | $456K | 2026-07-29 |
| RA Capital Management, L.P. | Director & 10% Owner | Buy | $413K | 2026-07-24 |
| RA Capital Management, L.P. | Director & 10% Owner | Buy | $2.6M | 2026-07-21 |